Treatment of Chronic Idiopathic Constipation

Efficacy of Psyllium

The American Gastroenterological Association and the American College of Gastroenterology recommend psyllium as the only fiber supplement with solid evidence of efficacy for chronic idiopathic constipation, with a significant increase in weekly bowel movements (mean difference: 2.32, CI 0.86-3.79) 1, 2, 3, 4, 5
Psyllium improves overall symptom relief (RR 1.86, CI 1.49-2.30), resulting in 391 more patients experiencing improvement per 1,000 compared to placebo 6, 7
The American College of Gastroenterology guidelines state that among all fiber supplements evaluated, only psyllium appears to be effective (with limited and uncertain data on bran and inulin, and no mention of guar gum as a recommended option) 1, 2, 8

The American Gastroenterological Association and the American College of Gastroenterology guidelines do not recommend guar gum as a therapeutic option for chronic idiopathic constipation, with no significant additional effect on bowel movement frequency, stool consistency, or laxative use when added to a high-fiber diet (30 g/day) 1, 2, 9, 8
Guar gum is only briefly mentioned in the 2023 guidelines as part of a mixture with inulin, but this combination showed little or no effect on weekly bowel movements (DM -0.75, CI -2.60 to 1.10) 9

The effective dose of psyllium is >10 g/day, divided into two doses (typically 5 g twice a day), with a minimum treatment duration of ≥4 weeks to achieve optimal benefit 1, 10
Adequate hydration is crucial, with each dose taken with 240-300 mL of water to avoid intestinal obstruction 1, 10

Psyllium can cause intestinal obstruction if not taken with adequate liquids, especially with prolonged use or in elderly patients, with common side effects including flatulence (more frequent than with placebo: DME 0.80, CI 0.47-1.13) and abdominal distension 1, 10

The American Gastroenterological Association and other guideline societies do not recommend psyllium for opioid-induced constipation (OIC), as it may worsen symptoms in this population, and instead suggest osmotic laxatives (PEG, lactulose) or stimulant laxatives (senna, bisacodyl) as first-line options 11, 12
Bulk laxatives, such as psyllium, should be avoided in non-ambulatory patients due to the risk of intestinal obstruction 12

If psyllium treatment is inadequate after 4 weeks, consider escalating to osmotic or stimulant laxatives, as recommended by the American Gastroenterological Association and other guideline societies 11, 12